dc.contributor.author |
Bark, Charles M. |
|
dc.contributor.author |
Manceur, Ameur M. |
|
dc.contributor.author |
Malone, LaShaunda L. |
|
dc.contributor.author |
Nsereko, Mary |
|
dc.contributor.author |
Okware, Brenda |
|
dc.contributor.author |
Mayanja, Harriet K. |
|
dc.contributor.author |
Joloba, Moses L. |
|
dc.contributor.author |
Rajotte, Isabelle |
|
dc.contributor.author |
Mentinova, Marija |
|
dc.contributor.author |
Kay, Phyla |
|
dc.contributor.author |
Lo, Seydina |
|
dc.contributor.author |
Tremblay, Patrick |
|
dc.contributor.author |
Stein, Catherine M. |
|
dc.contributor.author |
Boom, W. Henry |
|
dc.contributor.author |
Paramithiotis, Eustache |
|
dc.date.accessioned |
2021-01-01T21:58:13Z |
|
dc.date.available |
2021-01-01T21:58:13Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
2352-3964 |
|
dc.identifier.uri |
http://combine.alvar.ug/handle/1/48220 |
|
dc.description.abstract |
The objective of this study was to identify blood-based protein biomarkers of early stage Mycobacterium tuberculosis (Mtb) infection. We utilized plasma and serum specimens from TB patients and their contacts (age >= 12) enrolled in a household contact study in Uganda. In the discovery phase cross-sectional samples from 104 HIV-uninfected persons classified as either active TB, latent Mtb infection (LTBI), tuberculin skin test (TST) converters, or persistent TST-negative were analyzed. Two hundred eighty-nine statistically significant (false discovery rate corrected p < 0.05) differentially expressed proteins were identified across all comparisons. Proteins associated with cellular immunity and lipid metabolism were induced early after Mtb infection. One hundred and fifty-nine proteins were selected for a targeted mass spectrometry assay. A set of longitudinal samples from 52 TST-negative subjects who converted to TST-positive or remained TST-negative were analyzed, and multivariate logistic regression was used to identify unique protein panels able to predict TST conversion with cross-validated AUC > 0.85. Panel performance was confirmed with an independent validation set of longitudinal samples from 16 subjects. These candidate protein biomarkers may allow for the identification of recently Mtb infected individuals at highest risk for developing active TB and most likely to benefit from preventive therapy. (C) 2017 The Authors. Published by Elsevier B.V. |
|
dc.description.sponsorship |
National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [HHSN272200800047C] |
|
dc.description.sponsorship |
Tuberculosis Research Unit from the National Institutes of Health National Institute of Allergy and Infectious Diseases [N01-AI95383, HHSN266200700022C/N01-AI70022] |
|
dc.description.sponsorship |
NIH/NCRR CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR) [KL2TR000440] |
|
dc.description.sponsorship |
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000440, KL2TR000440, KL2TR000440, KL2TR000440, KL2TR000440] Funding Source: NIH RePORTER |
|
dc.description.sponsorship |
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [N01AI095383, N01AI095383, N01AI095383, N01AI095383, N01AI095383, N01AI095383] Funding Source: NIH RePORTER |
|
dc.language |
English |
|
dc.publisher |
ELSEVIER SCIENCE BV |
|
dc.relation.ispartof |
Ebiomedicine |
|
dc.subject |
Tuberculosis |
|
dc.subject |
Proteomics |
|
dc.subject |
Ltbi |
|
dc.subject |
Converter |
|
dc.title |
Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection |
|
dc.type |
Article |
|
dc.identifier.isi |
000409430700024 |
|
dc.identifier.doi |
10.1016/j.ebiom.2017.06.019 |
|
dc.identifier.pmid |
28655597 |
|
dc.publisher.city |
AMSTERDAM |
|
dc.publisher.address |
PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS |
|
dc.identifier.volume |
21 |
|
dc.identifier.spage |
150 |
|
dc.identifier.epage |
157 |
|
dc.subject.wc |
Medicine, General & Internal |
|
dc.subject.wc |
Medicine, Research & Experimental |
|
dc.subject.sc |
General & Internal Medicine |
|
dc.subject.sc |
Research & Experimental Medicine |
|
dc.description.oa |
DOAJ Gold |
|
dc.description.oa |
Green Published |
|
dc.description.pages |
8 |
|
dc.subject.kwp |
Latent Tuberculosis |
|
dc.subject.kwp |
Household Contact |
|
dc.subject.kwp |
Individuals |
|
dc.subject.kwp |
Metabolism |
|
dc.subject.kwp |
Biomarkers |
|
dc.subject.kwp |
Proteomics |
|
dc.subject.kwp |
Kampala |
|
dc.subject.kwp |
Uganda |
|
dc.description.affiliation |
Case Western Reserve Univ, TB Res Unit, 10900 Euclid Ave, Cleveland, OH 44106 USA |
|
dc.description.affiliation |
Caprion Biosci, 201 President Kennedy Ave, Montreal, PQ H2X 3Y7, Canada |
|
dc.description.affiliation |
Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda |
|
dc.description.affiliation |
Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda |
|
dc.description.affiliation |
Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda |
|
dc.description.affiliation |
Metrohlth Med Ctr, Div Infect Dis, Cleveland, OH USA |
|
dc.description.email |
cmb148@case.edu |
|
dc.description.corr |
Bark, CM (corresponding author), Case Western Reserve Univ, TB Res Unit, 10900 Euclid Ave, Cleveland, OH 44106 USA. |
|
dc.description.orcid |
Stein, Catherine/0000-0002-9763-5023 |
|
dc.description.orcid |
Mayanja-Kizza, Harriet/0000-0002-9297-6208 |
|